Medtronic plc

MDTNYSEHealthcare● Active

$81.67

$-0.26(-0.32%)

Market Cap$104.9B

P/E Ratio—

52W High$106.33

52W Low$73.31

Avg Volume9.6M

Open$82.10

Beta0.60

PE Ratio Market Cap Forecast

Medtronic plc (MDT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mdt · pe ratio · data through Apr 24, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Medtronic plc (MDT) measures how much investors pay for each dollar of the company's trailing earnings. MDT's current PE ratio of 21.81x is calculated by dividing its stock price of $81.67 by its TTM earnings per share of $3.74. −18.8% discount vs 5Y avg 26.9x

21.81x

P/E Ratio (TTM)−18.8%

Source: FMP · /ratios-ttm · /analyst-estimates · 2026-04-24

Forward P/E

12.76x

FY2028 est. EPS $6.40

Based on 15 analysts

EPS (TTM)

$3.74

TTM · diluted EPS

PEG Ratio

6.60

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medtronic plc SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2007 – 2026 · Annual

PE Ratio (TTM)

5Y Avg 26.9x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 20 fiscal years · Front-end computed

Average

25.0x

20-yr mean

Median

25.2x

20-yr midpoint

Minimum

11.1x

Lowest year

Maximum

48.8x

Highest year

21.8x ← Now

11.1x
MinQ1 · 25%25.2x
MedianQ3 · 75%48.8x
Max

Within Historical Range

At 21.81x, MDT's current P/E is within its average historical range over the past 20 fiscal years.

35th percentileHigher than 7 of 20 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Medtronic plcYou MDT	$104.9B	21.81x	-31.2%	$3.74
Bristol-Myers Squibb Company BMY	$116.9B	15.61x	-50.7%	$3.46
Boston Scientific Corporation BSX	$72.2B	48.91x	+54.3%	$1.95
CVS Health Corporation CVS	$122.4B	56.87x	+79.4%	$1.40
Edwards Lifesciences Corporation EW	$49.5B	46.44x	+46.5%	$1.84
GSK plc GSK	$103.6B	6.45x	-79.7%	$5.64
HCA Healthcare, Inc. HCA	$82.6B	15.88x	-49.9%	$29.40
Industry Average 6 peers with valid PE	—	31.69x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2026-04-24Latest FY2026	22.25x	$3.74	-4.1%
2025-04-25 FY2025	23.21x	$3.63	-19.4%
2024-04-26 FY2024	28.80x	$2.77	-10.5%
2023-04-28 FY2023	32.18x	$2.83	+15.8%
2022-04-29 FY2022	27.80x	$3.75	-43.1%
2021-04-30 FY2021	48.83x	$2.68	+75.6%
2020-04-24 FY2020	27.80x	$3.57	+7.7%
2019-04-30 FY2019	25.82x	$3.44	-26.3%
2018-04-30 FY2018	35.02x	$2.29	+22.2%
2017-04-30 FY2017	28.67x	$2.92	-9.1%

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $81.67 ÷ $3.74 = 21.81x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

MDT pe ratio · 6 questions

MDT's current PE ratio is 21.81x as of 2026-06-08, based on a stock price of $81.67 and TTM EPS of $3.74. Data sourced from Financial Modeling Prep via MDT's SEC 10-K and 10-Q filings.

MDT PE ratioWhat is MDT PE ratioCurrent PE ratio of MDTMDT PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medtronic plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08